CATEGORIES FOR POSTER PRESENTATION
|
•
|
Cardiopulmonary Transition
|
•
|
Pulmonary Diseases, Respiratory Care, Surfactant
|
•
|
BPD and Respiratory Outcome
|
•
|
Nutrition
|
•
|
Brain, Pain and ROP
|
•
|
Neurodevelopmental Outcome
|
•
|
The Neonatal Immune System and Immunodeficiencies
|
•
|
Infections and Inflammation
|
•
|
Epidemiology
|
•
|
Drugs
|
•
|
Miscellaneous Topics
|
|
|
|
ABSTRACT SUBMISSION GUIDELINES
|
•
|
Clearly state: Background, Objective, Methods, Results & Conclusions
|
|
(Maximum: 400 words).
|
•
|
The abstract has to be submitted in English.
|
•
|
At the top of the abstract, please show names of the authors and their institutional affiliation; first initial(s) precedes last names.
|
•
|
Please indicate/mark the presenting author and state his/her complete address and e-mail for correspondence.
|
•
|
The entire abstract (arial, font size 11) should not exceed 400 words, please see example.
|
•
|
All abstracts are peer reviewed by an expert panel.
|
•
|
Authors will be notified whether their abstract has been selected for poster presentation within 4 weeks after submission at the latest.
|
•
|
The author of an accepted abstract must register for the congress within 2 weeks after receiving notification of acceptance.
|
•
|
For abstract presenting delegates from low-income and lower-middle-income countries a special registration fee will be offered.
|